Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro

Biomedicine and Pharmacotherapy

Volumn 66, Issue 3, 2012, Pages 187-194

  Yang, Shouhui ^a   Liu, JinJuan ^a   Chen, Yongqiang ^a   Jiang, Jihong ^a  

^a JIANGSU NORMAL UNIVERSITY   (China)

Author keywords

Multidrug resistance; P glycoprotein; Reversal; Tween 20

Indexed keywords

DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; MESSENGER RNA; POLYSORBATE 20; VINCRISTINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRAIN HEPG2; CELL STRUCTURE; CYTOTOXICITY; DOWN REGULATION; DRUG ABSORPTION; DRUG ACCUMULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSAL REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROFLUOROMETRY; TUMOR CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL DIVISION; CELL LINE, TUMOR; DOWN-REGULATION; DOXORUBICIN; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; G2 PHASE; GENE EXPRESSION; HEP G2 CELLS; HUMANS; P-GLYCOPROTEIN; POLYSORBATES; VINCRISTINE;

EID: 84862812771     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.10.007     Document Type: Article

References (35)

1. Ambudkar S.V., Kimchi-Sarfaty C., Sauna Z.E., Gottesman M.M. P-glycoprotein: from genomics to mechanism. Oncogene 2003, 22:7468-7485. [PubMed: 14576852].
2. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002, 2:48-58. [PubMed: 11902585].
3. Nielsen D., Skovsgaard T. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochim Biophys Acta 1992, 1139:169-183. [PubMed: 1392705].
4. Deeley R.G., Cole S.P. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett 2006, 580:1103-1111. [PubMed: 16387301].
5. Bradley G., Juranka P.F., Ling V. Mechanism of multidrug resistance. Biochim Biophys Acta 1988, 948:87-128. [PubMed: 2899442].
6. Krishna R., Mayer L.D. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 2000, 11:265-283. [PubMed: 11033070].
7. Tan B., Piwnica-Worms D., Ratner L. Multidrug resistance transporters and modulation. Curr Opin Oncol 2000, 12:450-458. [PubMed: 10975553].
8. Yang L, Wei DD, Chen Z, Wang JS, Kong LY. Reversal of multidrug resistance in human breast cancer cells by Curcuma wenyujin and Chrysanthemum indicum. Phytomedicine 2011 [PubMed: 21306883].
9. Xiang W., Gao A., Liang H., Li C., Gao J., Wang Q., et al. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells. Toxicol In Vitro 2010, 24:1474-1481. [PubMed: 20656007].
10. Loe D.W., Deeley R.G., Cole S.P. Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). J Pharmacol Exp Ther 2000, 293:530-538. [PubMed: 10773025].
11. Barancik M., Bohacova V., Sedlak J., Sulova Z., Breier A. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. Eur J Pharm Sci 2006, 29:426-434. [PubMed: 17010577].
12. Bellamy W.T., Dalton W.S., Dorr R.T. The clinical relevance of multidrug resistance. Cancer Invest 1990, 8:547-562. [PubMed: 1979932].
13. Kerb R., Hoffmeyer S., Brinkmann U. ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics 2001, 2:51-64. [PubMed: 11258197].
14. Coon J.S., Knudson W., Clodfelter K., Lu B., Weinstein R.S. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Cancer Res 1991, 51:897-902. [PubMed: 1988130].
15. Friche E., Jensen P.B., Sehested M., Demant E.J., Nissen N.N. The solvents cremophor EL and Tween-80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer Commun 1990, 2:297-303. [PubMed: 1976341].
16. Yamazaki T., Sato Y., Hanai M., Mochimaru J., Tsujino I., Sawada U., et al. Non-ionic detergent Tween-80 modulates VP-16 resistance in classical multidrug resistant K562 cells via enhancement of VP-16 influx. Cancer Lett 2000, 149:153-161. [PubMed: 10737719].
17. Tahara K., Kato Y., Yamamoto H., Kreuter J., Kawashima Y. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells. J Microencapsul 2011, 28:29-36. [PubMed: 21171814].
18. Bhattacharjee J., Verma G., Aswal V.K., Date A.A., Nagarsenker M.S., Hassan P.A. Tween-80-sodium deoxycholate mixed micelles: structural characterization and application in doxorubicin delivery. J Phys Chem B 2010, 114:16414-16421. [PubMed: 21080698].
19. Omokawa Y., Miyazaki T., Walde P., Akiyama K., Sugahara T., Masuda S., et al. In vitro and in vivo anti-tumor effects of novel Span 80 vesicles containing immobilized Eucheuma serra agglutinin. Int J Pharm 2010, 389:157-167. [PubMed: 20100554].
20. Lo Y.L. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J Control Release 2003, 90:37-48. [PubMed: 12767705].
21. Lo Y.L., Hsu C.Y., Huang J.D. Comparison of effects of surfactants with other MDR reversing agents on intracellular uptake of epirubicin in Caco-2 cell line. Anticancer Res 1998, 18:3005-3009. [PubMed: 9713500].
22. Jin J., Huang M., Wei H.L., Liu G.T. Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel (7402). World J Gastroenterol 2002, 8:1029-1034. [PubMed: 12439919].
23. Jin J., Wang F.P., Wei H., Liu G. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Cancer Chemother Pharmacol 2005, 55:179-188. [PubMed: 15378274].
24. Nakayama G.R., Caton M.C., Nova M.P., Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 1997, 204:205-208. [PubMed: 9212838].
25. Labeed F.H., Coley H.M., Thomas H., Hughes M.P. Assessment of multidrug resistance reversal using dielectrophoresis and flow cytometry. Biophys J 2003, 85:2028-2034. [PubMed: 12944315].
26. Tolis C., Peters G.J., Ferreira C.G., Pinedo H.M., Giaccone G. Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines. Eur J Cancer 1999, 35:796-807. [PubMed: 10505042].
27. Huang M., Liu G. The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line. Cancer Lett 1999, 135:97-105. [PubMed: 10077227].
28. Terzis G., Georgiadis G., Vassiliadou E., Manta P. Relationship between shot put performance and triceps brachii fiber type composition and power production. Eur J Appl Physiol 2003, 90(1-2):10-15.
29. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993, 62:385-427. [PubMed: 8102521].
30. Quan F., Pan C.E., Zhang S.Q., Yan L.Y., Yu L. Reversal effect of resveratrol on chemotherapy resistance in KBv200 cell line and underlying mechanisms. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2009, 44:63-68. [PubMed: 19484992].
31. Callaghan R., Berridge G., Ferry D.R., Higgins C.F. The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface. Biochim Biophys Acta 1997, 1328:109-124. [PubMed: 9315609].
32. Dudeja P.K., Anderson K.M., Harris J.S., Buckingham L., Coon J.S. Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Arch Biochem Biophys 1995, 319:309-315. [PubMed: 7771801].
33. Sakai M., Imai T., Ohtake H., Azuma H., Otagiri M. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. J Pharm Sci 1997, 86:779-785. [PubMed: 9232516].
34. Tsujino I., Yamazaki T., Masutani M., Sawada U., Horie T. Effect of Tween-80 on cell killing by etoposide in human lung adenocarcinoma cells. Cancer Chemother Pharmacol 1999, 43:29-34. [PubMed: 9923538].
35. Rege B.D., Kao J.P., Polli J.E. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 2002, 16:237-246. [PubMed: 12208453].